Petitioner: DEPARTMENT OF HEALTH, BOARD OF MEDICINE
Respondent: FERNANDO VALLE, M.D.
Judges: R. BRUCE MCKIBBEN
Agency: Department of Health
Locations: Orlando, Florida
Filed: Sep. 26, 2012
Status: Closed
Settled and/or Dismissed prior to entry of RO/FO on Thursday, March 7, 2013.
Latest Update: Nov. 19, 2024
STATE OF FLORIDA
DEPARTMENT OF HEALTH
FLORIDA DEPARTMENT OF HEALTH,
Petitioner,
V. Case Number: 2012-06492
FERNANDO VALLE, M.D.,
Respondent.
ADMINISTRATIVE COMPLAINT
Petitioner Department of Health files this Administrative Complaint
before the Board of Medicine against Respondent Fernando Valle, M.D.,
and states:
1a Petitioner is the state agency charged with regulating the
practice of medicine, pursuant to Chapters 20, 456 and 458, Florida
Statutes (2010-2011).
2. At all times material to this Complaint, Respondent was
licensed to practice as a physician in the State of Florida, pursuant to
Chapter 458, Florida Statutes (2010-2011), having been issued license
number ME41752. Respondent's address of record is 10459 Belfry Circle,
Orlando, Florida 32832.
3. At all times material to this Complaint, Respondent treated
Filed September 26, 2012 3:44 PM Division of Administrative Hearings
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
patients at A New Life Pain Management Clinic (the “Clinic”), a pain
management clinic located at 40 Barkley Cir # 3, Fort Myers, FL 33907.
FACTS SPECIFIC TO J.P.
4. Onor about December 21, 2011, Law Enforcement officer J.P.
(JP”), acting in an undercover capacity, first presented to the Clinic as a
twenty-eight-year-old female patient with complaints of neck/upper back
and shoulder pain. JP provided copies of her medica! record from a prior-
treating physician to the Clinic. JP’s prior medical record included the
results of a magnetic resonance imaging (“MRI”) study of JP’s lumbar spine
(lower back) dated November 28, 2011, and JP’s prescription history.’
JP’s medical record revealed a mild disc protrusion and a history of no prior
surgery or treatments to her lower back. JP did not complain of pain to
her lower back during her visit to the Clinic, but instead complained of pain
to her neck, upper back and shoulder. JP’s medical record included a
history of receiving Oxycodone 30 mg, Xanax 2 mg and Ibuprofen 600 mg
from December 2, 2010, through November 11, 2011.
5. Oxycodone is commonly prescribed to treat pain. According to
Section 893.03(2), Florida Statutes (2010-2011), oxycodone is a Schedule
' Jp’s medical record and prescription history were fabricated by Law Enforcement with the assistance of a
cooperating physician. JP’s MRI was authentic.
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
II controlled substance that has a high potential for abuse and has a
currently accepted but severely restricted medical use in treatment in the
United States. Abuse of oxycodone may lead to severe psychological or
physical dependence.
6. Xanax is the brand name for alprazolam and is prescribed to
treat anxiety. According to Section 893.03(4), Florida Statutes (2010-
2011), alprazolam is a Schedule IV controlled substance that has a low
potential for abuse relative to the substances in Schedule III and has a
currently accepted medical use in treatment in the United States. Abuse of
alprazolam may lead to limited physical or psychological dependence
relative to the substances in Schedule III.
7. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID)
used to reduce fever and treat pain or inflammation.
8. During the course of this initial visit, JP reported a pain level of
five on a scale of one-through-ten without pain medication and two on a
scale of one-through-ten with pain medication. JP was asked by a medical
assistant at the Clinic to undergo a urine drug screen, which was negative
for any substances, including those controlled substances that were
previously prescribed to JP.
Florida Department of Health vy. Fernando Valle, M.D,
Case Number: 2012-06492
9. After paying her visit fee of $125.00, JP was escorted into an
examination room, where she was met by Dr. Valle. Dr. Valle then
proceeded to perform a physical examination of JP. During the
examination, which lasted less than three minutes, JP remained seated.
10. Following the examination, Dr. Valle advised JP that “there's
not much wrong with your back.” Dr. Valle informed JP that he would not
prescribe a CAT (Computed Axial Tomography) scan or MRI for JP because
he did not want to expose her to radiation. Dr. Valle further informed JP
that she appeared to have a heart murmur and should see a cardiologist.
Dr. Valle did not, however, provide JP with a referral to a cardiologist.
11. At the conclusion of this visit, Dr. Valle provided JP with
prescriptions for.60 dosage units of Roxicodone 30 mg, 60 dosage units of
MS Contin 30 mg, 30 dosage units of Xanax 2 mg, 60 dosage units of
Naprosyn 250 mg and 30 dosage units of Flexeril 10 mg.
12. Roxicodone is a brand name for oxycodone.
13. MS Contin is the brand name for a drug that contains morphine
and is prescribed to treat pain. According to Section 893.03(2), Florida
Statutes (2010-2011), morphine is a Schedule II controlled substance that
has a high potential for abuse and has a currently accepted but severely
Florida Department of Héalth v. Fernando Valle, M.D.
Case Number: 2012-06492
restricted medical use in treatment in the United States. Abuse of
morphine may lead to severe psychological or physical dependence.
14. Naprosyn is a nonsteroidal anti-inflammatory drug (NSAID) and
is used to treat pain or inflammation.
15. On or about January 17, 2012, JP went to the Clinic for a
follow-up visit with Dr. Valle. After paying a visit fee of $225.00, JP was
escorted to an examination room where a medical assistant took JP’s
weight and inquired about JP’s pain level. In response, JP reported a pain
level of five on a scale of one-through-ten without pain medication and
three on a scale of one-through-ten with pain medication. JP then advised
the medical assistant that four days prior to this visit, she had ingested the
last of the Oxycontin 30 mg Dr. Valle had prescribed to her during prior
visit.
16. Upon entering the examination room, Dr. Valle noted that JP
was not scheduled for an appointment until January 18, 2012. When JP
explained that she was early because she could not make the January 18"
appointment, Dr. Valle then questioned JP about why she had finished a
thirty-day supply of Oxycontin 30 mg in just twenty days. JP told Dr. Valle
that she had stopped taking the MS Contin he had prescribed to her
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
because it was not working for her and that she had resorted to taking
more of the Oxycontin 30 mg as a consequence.
17. Dr. Valle then proceeded to perform a physical examination of
JP’s upper back and shoulder area, which lasted a total of approximately
five seconds. JP remained seated during the entire examination. Dr. Valle
then advised JP that he would not require her to undergo an MRI of her
upper back because it was unnecessary.
18. At the conclusion of this visit, Dr. Valle prescribed 90 dosage
units of Roxicodone 30 mg, 30 dosage units of Xanax 2 mg, 60 dosage
units of Naprosyn 250 mg, 30 dosage units of Flexeril 10 mg and 60
dosage units of Tramadol 200 mg to JP. JP’s visit with Dr. Valle lasted a
total of eight minutes.
19. Flexeril is a muscle relaxant used to treat skeletal muscle
conditions such as pain or injury.
20. Tramadol is an opioid-class medication prescribed to treat pain.
Tramadol is a legend drug, but not a controlled substance. Tramadol can
affect mental alertness, is subject to abuse and can be habit forming.
21. An independent medical expert, who is Board-Certified in Pain
Management, Anesthesiology and Interventional Pain Management,
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
reviewed the treatment provided by Dr. Valle to JP and opined Dr. Valle fell
below the standard of care in several respects. In particular, the expert
found Dr. Valle failed to utilize a multi-disciplinary approach in his
treatment of JP; prescribed controlled substances to the patient without
medical justification; failed to perform radiologic or physical examinations
of the patient’s neck or shoulder areas (the patient's main complaint);
failed to provide a written treatment plan to the patient; failed to order
diagnostic or objective tests; and prescribed controlled substances to JP
after the patient reported running out of medication early, reported no
increases in pain and tested negative for the substances during drug
screens.
Facts Specific to P.S.
22. On or about January 11, 2012, Law Enforcement officer P.S.
(“PS”), acting in an undercover capacity, first presented to the Clinic as a
thirty-eight-year-old male patient with complaints of lower back pain. After
paying an initial visit fee of $125.00, PS was escorted into an examination
room by a medical assistant. PS provided copies of his medical record
from a prior-treating physician to the Clinic. PS’s prior medical record
included the results of a MRI study of PS’s neck/upper back dated
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
December 19, 2011, which revealed a small disc herniation in PS’s upper
back, but no other abnormalities.”
23. During the course of this initial visit, PS reported a pain level of
five on a scale of one-through-ten without pain medication and two on a
scale of one-through-ten with pain medication. PS was asked by a medical
assistant at the Clinic to undergo a urine drug screen.
24. After entering the examination room, Dr. Valle advised PS that
he would need to obtain an MRI of his lower back in order to be seen for
his back pain. Dr. Valle then provided PS with a prescription for an MRI
and told PS to return to the Clinic after undergoing the MRI. Dr. Valle did
not perform an examination of PS at any time during this visit.
25. On January 30, 2012, PS returned to the Clinic for a follow-up
visit. PS brought the results of an X-ray of his lower back to this visit.
Contrary to the prescription provided by Dr. Valle, PS did not undergo an
MRI. After being escorted into an examination room, PS again reported a
pain level of five on a scale of one-through-ten without pain medication
and two on a scale of one-through-ten with pain medication.
26. Upon entering the examination room where PS was waiting, Dr.
2 PS’s medical record and prescription history were fabricated by Law Enforcement with the assistance of a
cooperating physician. PS’s MRI was authentic.
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
Valle described the results of PS’s X-ray as “not that bad” and asked PS
how many dosage units of oxycodone 30 mg he had taken in the past
seven days. PS advised Dr. Valle he had taken an average of four
oxycodone 30 mg per day despite the fact that PS did not have a current
prescription for oxycodone 30 mg. Dr. Valle proceeded to conduct an
examination of PS that lasted approximately sixty-five seconds. During the
‘examination, PS remained seated and did not complain of pain. At the
conclusion of this visit, Dr. Valle prescribed 120 dosage units of Roxicodone
30 mg, 60 dosage units of MS Contin 15 mg and 30 dosage units of Mobic
15 mg. Dr. Valle failed to discuss any other treatment options with PS.
27. Mobic is a nonsteroidal anti-inflammatory drug (NSAID) used to
treat pain or inflammation caused by arthritis.
28. On or about February 27, 2012, PS returned to the Clinic for a
follow-up visit with Dr. Valle. After being escorted into an examination
room by a medical assistant, PS again reported a pain level of five on a
scale of one-through-ten without pain medication and two on a scale of
one-through-ten with pain medication. PS also reported that he had run
out of Roxicodone 30 mg about five days prior to his visit to the Clinic.
After Dr. Valle entered the examination room, PS advised him that the MS
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
Contin Dr. Valle had prescribed to him during his prior visit had made him
nauseous. In response, Dr. Valle told PS he would discontinue his prior
prescription for MS Contin and increase his dosage units of oxycodone 30
mg.
29, At the end of this visit, which lasted approximately six minutes,
Dr. Valle prescribed 150 dosage units of oxycodone 30 mg (an increase of
30 dosage units from the previous visit) to PS. Dr. Valle did not conduct a
physical examination of PS during this visit.
30. An independent medical expert, who is Board-Certified in Pain
Management, Anesthesiology and Interventional Pain Management,
reviewed the treatment provided by Dr. Valle to PS and opined Dr. Valle fell
below the standard of care in several ways. In particular, the expert found
Dr. Valle performed inadequate or no physical examinations of the patient,
failed to utilize a multi-disciplinary approach in his treatment of the patient;
prescribed controlled substances to the patient without medical
justification; failed to provide a written treatment plan to the patient, and
prescribed controlled substances to the patient after the patient reported
running out of medication early, reported no increases in pain and tested
negative for the substances during drug screens.
10
Florida Department of Health v. Fernando Vaile, M.D.
Case Number: 2012-06492
COUNT I — SECTION 458.331(1)(t), FLORIDA STATUTES
37. Petitioner realleges and incorporates paragraphs 1 through 30
above, as if set forth herein.
38. Section 458.331(1)(t)1, Florida Statutes (2010-2011), subjects
a physician to discipline, including suspension, for committing medical
malpractice as defined in Section 456.50, Florida Statutes (2010-2011).
“Medical malpractice” is defined by Section 456.50(1)(g), Florida Statutes
(2010-2011), as “the failure to practice medicine in accordance with the
level of care, skill, and treatment recognized in general law related to
health care licensure.” Section 456.50(1)(e), Florida Statutes (2010-2011),
provides that the “level of care, skill, and treatment recognized in general
jaw related to health care licensure" means the standard of care that is
specified in Section 766.102(1), Florida Statutes (2010-2011), which states
as follows:
The prevailing professional standard of care for a given health
care provider shall be that level of care, skill, and treatment
which, in light of all relevant surrounding circumstances, is
recognized as acceptable and appropriate by reasonably
prudent similar health care providers.
11
.. Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
39. Section 458.331(1)(t)1., Florida Statutes (2010-2011), directs
the Board of Medicine to give “great weight” to this provision of Section
766.102, Florida Statutes (2010-2011). .
40. Respondent failed to meet the prevailing standard of care and,
therefore, violated Section 458.331(1)(t)1., Florida Statutes (2010-2011),
in one or more of the following manners:
a. By prescribing inappropriate quantities of controlled
substances to Patients JP and PS without justification;
b. By failing to employ other modalities for the treatment of
pain in connection with Patients JP and PS; and
c. By failing to order appropriate diagnostic or objective
tests for Patients JP and PS.
COUNT II — SECTION 458.331(1)(q), FLORIDA STATUTES
31. Petitioner realleges and incorporates paragraphs 1 through 30
above, as if set forth herein.
32. Section 458.331(1)(q), Florida Statutes (2010-2011), subjects a
licensee to discipline for prescribing, dispensing, administering, mixing, or
otherwise preparing a legend drug, including any controlled substance,
other than in the course of the physician's professional practice. It is legally
12
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
presumed that prescribing, dispensing, administering, mixing, or otherwise
preparing legend drugs, including all controlled substances, inappropriately
or in excessive or inappropriate quantities is not in the best interest of the
patient and is not in the course of the physician's professional practice,
without regard to his or her intent. |
33. Respondent violated Section 458.331(1)(q), Florida Statutes
(2010-2011), by prescribing controlled substances inappropriately or in
excessive or inappropriate quantities to Patients JP and PS.
COUNT III — SECTION 458.331(1)(nn), FLORIDA STATUTES
34. Petitioner realleges and incorporates paragraphs 1 through 30
above, as if set forth herein.
35. Section 458.331(1)(nn), Florida Statutes (2010-2011), subjects
a physician to discipline for violating any provision of Chapters 456 or 458,
Florida Statutes, or any rules adopted pursuant thereto.
36. Rule 6488-9.013, Florida Administrative Code, sets forth
standards for the use of controlled substances for the treatment of pain, in
part, as follows:
(3) Standards. The Board has adopted the following
standards for the use of controlled substances for pain control:
(a) Evaluation of the Patient. A complete medical history
13
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
and physical examination must be conducted and documented
in the medical record. The medical record shall document the
nature and intensity of the pain, current and past treatments
for pain, underlying or coexisting diseases or conditions, the
effect of the pain on physical and psychological function, and
history of substance abuse. The medical record also shall
document the presence of one or more recognized medical
indications for the use of a controlled substance.
(b) Treatment Plan. The written treatment plan shall state
objectives that will be used to determine treatment success,
such as pain relief and improved physical and psychosocial
function, and shall indicate if any further diagnostic evaluations
or other treatments are planned. After treatment begins, the
physician shall adjust drug therapy, if necessary, to the
individual medical needs of each patient. Other treatment
modalities or a rehabilitation program may be necessary
depending on the etiology of the pain and the extent to which
the pain is associated with physical and _ psychosocial
impairment.
(e) Consultation. The physician shall be willing to refer
the patient as necessary for additional evaluation and
treatment in order to achieve treatment objectives. Special
attention must be given to those pain patients who are at risk
for misusing their medications and those whose living
arrangements pose a risk for medication misuse or diversion.
The management of pain in patients with a history of substance
abuse or with a comorbid psychiatric disorder requires extra
care, monitoring, and documentation, and may require
consultation with or referral to an expert in the management of
such patients.
(f) Medical Records. The physician is required to keep
accurate and complete records to include, but not be limited to:
1. The complete medical history and a_ physical
14
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
examination, including history of drug abuse or dependence,
as appropriate;
2. Diagnostic, therapeutic, and laboratory results;
3. Evaluations and consultations;
4. Treatment objectives;
37. Respondent violated Rule 64B8-9.013, Florida Administrative
Code, in one or more of the following manners:
a. By failing to document an adequate treatment plan for
Patients JP and PS.
b. By failing to conduct or document an adequate physical
examination of Patients JP and PS;
c. By failing to document adequate justification for the
prescription of controlled substances to Patients JP and PS;
and
d. By failing to appropriately monitor Patients JP and PS for
drug diversion or drug abuse.
WHEREFORE, Petitioner respectfully requests the Board of Medicine
enter an order imposing one or more of the following penalties: permanent
revocation or suspension of Respondent's license, restriction of practice,
imposition of an administrative fine, issuance of a reprimand, placement of
the Respondent on probation, corrective action, refund of fees billed or
15
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
collected, remedial education and/or any other relief the Board deems
appropriate.
SIGNED this__24* day of Sel, 2012.
John H. Armstrong, MD
State Surgeon General and
Secretary of Health
HBP
Daniel evhandez
Chief Legal Counsel
_ FILED DOH Prosecution Services Unit
DEPARTMENT OF HEALTH 4052 Bald Cypress Way, Bin C-65
CLERK Angel Sanders Tallahassee, FL 32399-3265
DATE JUL 25 2049. Florida Bar No.: 176834
(850) 245-4640
(850) 245-4681 FAX
PCP Members: Or, Nuss + Ms , Goerseh
PoP: 7/242
NOTICE OF RIGHTS
Respondent has the right to request a hearing to be
conducted in accordance with Section 120.569 and 120.57,
Florida Statutes, to be represented by counsel or other qualified
representative, to present evidence and argument, to call and
cross-examine witnesses and to have subpoena and subpoena
duces tecum issued on his or her behalf if a hearing is requested.
16
Florida Department of Health v. Fernando Valle, M.D.
Case Number: 2012-06492
NOTICE REGARDING ASSESSMENT OF COSTS
Respondent is placed on notice that Petitioner has incurred
costs related to the investigation and prosecution of this matter.
Pursuant to Section 456.072(4), Florida Statutes, the Board shall
assess costs related to the investigation and prosecution of a
disciplinary matter, which may include attorney hours and costs,
on the Respondent in addition any other discipline imposed.
17
Docket for Case No: 12-003217PL
Issue Date |
Proceedings |
Mar. 07, 2013 |
Order Closing File and Relinquishing Jurisduction. CASE CLOSED.
|
Mar. 07, 2013 |
Agreed Motion to Relinquish Jurisdiction filed.
|
Feb. 27, 2013 |
Order Denying Continuance or Abatement of Final Hearing.
|
Feb. 26, 2013 |
Petitioner's Response to Respondent's Motion to Abate Proceedings, or Alternatively Motion to Continue Formal Hearing filed.
|
Feb. 26, 2013 |
Respondent, Fernando Valle's Motion to Abate Proceedings or Alternatively Motion to Continue Formal Hearing filed.
|
Feb. 07, 2013 |
Notice of Transfer.
|
Jan. 17, 2013 |
Petitioner's Response To Respondent's Motion To Compel Discovery filed.
|
Jan. 16, 2013 |
Arbitrator's Notice of Calendar Conflict filed.
|
Jan. 16, 2013 |
Amended Notice of Hearing (hearing set for March 19 through 21, 2013; 9:00 a.m.; Orlando, FL; amended as to hearing location).
|
Jan. 04, 2013 |
Order Granting Continuance and Re-scheduling Hearing (hearing set for March 19 through 21, 2013; 9:00 a.m.; Orlando, FL).
|
Jan. 03, 2013 |
Second Unopposed Motion for Continuance of Proceedings filed.
|
Nov. 16, 2012 |
Notice of Serving Responses to Request for Production filed.
|
Nov. 16, 2012 |
Notice of Serving Responses to First Interrogatories filed.
|
Nov. 16, 2012 |
Notice of Serving Responses to Request for Admissions filed.
|
Oct. 19, 2012 |
Respondent's, Notice of Serving First Interrogatories to Petitioner filed.
|
Oct. 17, 2012 |
Order Granting Continuance and Re-scheduling Hearing (hearing set for January 15 through 18, 2013; 9:00 a.m.; Orlando, FL).
|
Oct. 15, 2012 |
Unopposed Motion for Continuance of Proceedings filed.
|
Oct. 11, 2012 |
Notice of Serving Petitioner's First Request for Admissions, Interrogatories and Production of Documents filed.
|
Oct. 11, 2012 |
Notice of Serving Petitioner's Responses to Respondent's First Request for Production and Petitioner's Responses to Respondent's First Request for Interrogatories filed.
|
Oct. 05, 2012 |
Order of Pre-hearing Instructions.
|
Oct. 05, 2012 |
Notice of Hearing (hearing set for November 13 through 16, 2012; 9:00 a.m.; Orlando, FL).
|
Oct. 04, 2012 |
Notice of Appearance (Daniel Hernandez) filed.
|
Oct. 03, 2012 |
Joint Response to the Initial Order filed.
|
Sep. 27, 2012 |
Initial Order.
|
Sep. 26, 2012 |
Agency referral filed.
|
Sep. 26, 2012 |
Election of Rights filed.
|
Sep. 26, 2012 |
Administrative Complaint filed.
|